Coronavirus: Asthma and Hay Fever

(asked on 21st April 2020) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 6 April (HL2662), what assessment they have made of the particular vulnerability of hay fever and asthma sufferers to COVID-19.


Answered by
Lord Bethell Portrait
Lord Bethell
This question was answered on 12th May 2020

At present there is insufficient evidence to determine whether there is any particular vulnerability of hay fever and asthma sufferers to COVID-19.

The British Thoracic Society’s Advice for Healthcare Professionals Treating People with Asthma (adults) in relation to COVID-19 and the National Institute for Health and Care Excellence’s COVID-19 rapid guideline: severe asthma, recommend that patients should continue taking their regular medications in line with their personalised asthma action plan. Some patients with severe asthma have been identified as being potentially extremely vulnerable to COVID-19 and been placed in the shielding group.

With regards to hay fever, the Global Initiative for Asthma and the Allergic Rhinitis and its Impact on Asthma organisation recommend that people with allergic rhinitis should continue to take their nasal corticosteroids, as prescribed by their healthcare professional.

Reticulating Splines